Olea europaea decreases hospital length of stay

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“Additionally, the length of hospitalization for intervention group A (MD=1.75, P<0.001) and intervention group B (MD=1.66, P<0.001) were significantly shorter than the control group.”

Quoted verbatim from Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial.

This finding among the 33 findings on its endpoint

Olea europaea

Hospital length of stay

lowers

Who: Hospitalised adults aged 18 to 72 with PCR-confirmed COVID-19 pneumonia, Tehran, Iran; 500 mg arm; all three arms also received dexamethasone, remdesivir, heparin and supplemental oxygen
Dose studied: 500 mg capsule every 12 hours for 5 days (intervention B)

Moderate evidencePMID 36319585 · 2023

02 · The study

Study: RCT
Duration: 5 days

Evidence, by strength

strong
moderatethis finding
limited
very limited
insufficient

03 · The paper

Explore (New York, N.Y.)

Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial.

2023PMID 36319585doi 10.1016/j.explore.2022.10.020

What else it reported2 findings · 0 compounds · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZNFWN4EW9T74VRXTBNKN37